The impact of 10-valent pneumococcal vaccine introduction on invasive disease in Fiji

BACKGROUND: In 2012, Fiji introduced the 10-valent pneumococcal conjugate vaccine (PCV10). We assessed the impact of PCV10 on invasive pneumococcal disease (IPD), probable bacterial or pneumococcal meningitis (PBPM), meningitis and sepsis 3-5 years post-introduction. METHODS: Laboratory-confirmed IP...

Descripción completa

Detalles Bibliográficos
Autores principales: Reyburn, R., Tuivaga, E.J., Ratu, F.T., Dunne, E.M., Nand, D., Kado, J., Jenkins, K., Tikoduadua, L., Jenney, A., Howden, B.P., Ballard, S.A., Fox, K., Devi, R., Satzke, C., Rafai, E., Kama, M., Flasche, S., Mulholland, E.K., Russell, F.M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741523/
https://www.ncbi.nlm.nih.gov/pubmed/35028629
http://dx.doi.org/10.1016/j.lanwpc.2021.100352

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741523/
https://www.ncbi.nlm.nih.gov/pubmed/35028629
http://dx.doi.org/10.1016/j.lanwpc.2021.100352

Ejemplares similares